Aneta Nowicka, MD, is a fourth-year internal medicine resident and a second-year PhD student at Poznan University of Medical Sciences. She earned her MD from the Karol Marcinkowski Medical University in Poznan in 2019. Since 2022, she has worked as a resident physician in the Department of Hematology and Bone Marrow Transplantation at the University Clinical Hospital in Poznan. Her scientific interests center on the role of the microbiome in health and disease, with a particular focus on hematology. She is especially interested in pharmacomicrobiomics, fecal microbiota transplantation, the cancer–microbiome–immune axis, microbiota in infectious diseases, and multi-omics approaches. She has been expanding her expertise in infectious complications, colonization, multidrug-resistant pathogens, antibiotherapy, and nutritional support in hematology. Her current doctoral project focuses on the influence of treatment on the course of infections in AML, aiming to improve clinical outcomes. Her work on the effects of fecal microbiota transplantation in patients undergoing hematopoietic stem cell transplantation was presented at the XXXI Congress of the Polish Society of Hematologists and Transfusionists. She is the author of the article "Microbial metabolomics in acute myeloid leukemia – from pathogenesis to treatment", published in Advances in Clinical and Experimental Medicine. She is a member of the Polish Society of Hematologists and Transfusionists.
